Khan AH, Reaney M, Guillemin I, Nelson L, Qin S, Kamat S, Mannent L, Amin N, Whalley D, Hopkins C. Development of Sinonasal Outcome Test (SNOT-22) domains in chronic rhinosinusitis with nasal polyps. Laryngoscope. 2022 May;132(5):933-41. doi: 10.1002/lary.29766
Han JK, Bachert C, Lee SE, Hopkins C, Heffler E, Hellings PW, Peters AT, Kamat S, Whalley D, Qin S, Nelson L, Siddiqui S, Khan AH, Li Y, Mannent LP, Guillemin I, Chuang CC. Estimating clinically meaningful change of efficacy outcomes in inadequately controlled chronic rhinosinusitis with nasal polyposis. Laryngoscope. 2022 Feb;132(2):265-71. doi: 10.1002/lary.29888
Shakoor A, Esterberg E, Acharya NR. Recurrence of uveitis after discontinuation of infliximab. Ocul Immunol Inflamm. 2014 Apr;22(2):96-101. doi: 10.3109/09273948.2013.812222
Martel JN, Esterberg E, Nagpal A, Acharya NR. Infliximab and adalimumab for uveitis. Ocul Immunol Inflamm. 2012 Feb;20(1):18-26. doi: 10.3109/09273948.2011.633205.
Mansfield CA, Pattanayak SK, McDow W, MacDonald R, Halpin P. Shades of green: measuring the value of urban forests in the housing market. J Forest Econ. 2005 Dec;11(3):177-99. doi: 10.1016/j.jfe.2005.08.002
Rothman KJ. The effect of alcohol consumption on risk of cancer of the head and neck. Laryngoscope. 1978 Jan;88(Suppl(pt 2)):51-5.